# Benchling

> Benchling is a cloud platform built for biotech R&D - a single, biology-first system of record where scientists design experiments, track samples, manage molecular data, and collaborate. Founded in 2012 out of MIT, it has grown into the operating system for modern life science, used by hundreds of thousands of scientists at companies ranging from startups to the largest biopharma firms, and is now embedding AI agents and predictive models directly into the lab workflow.

- **Founded:** 2012
- **Headquarters:** San Francisco, United States
- **Founders:** Sajith Wickramasekara (Co-founder & CEO), Ashu Singhal (Co-founder & President)
- **Team size:** ~800 employees
- **Products:** Notebook (ELN), Molecular Biology, Registry, Inventory, Workflows & Requests
- **Notable:** Grew from a single DNA-editing tool into a seven-app R&D Cloud used by 300,000+ scientists., Reached a $6.1B valuation at its 2021 Series F - reportedly a 122x trailing revenue multiple., Adopted by 20 of the 50 largest biopharma companies globally.

## Products & services

- **Notebook (ELN)** — A cloud electronic lab notebook for documenting experiments, protocols, and results with full data traceability.
- **Molecular Biology** — Tools for designing and annotating DNA, RNA, and protein sequences, cloning, and molecular modeling.
- **Registry** — A central registry that links biological entities and physical samples to their experimental records.
- **Inventory** — Sample and reagent inventory management with lineage tracking across the lab.
- **Workflows & Requests** — Process management for routing tasks, requests, and instrument data through the R&D lifecycle.
- **Insights** — Interactive dashboards and reporting for analyzing harmonized scientific data.
- **Benchling AI** — AI agents (Deep Research, Compose, Data Entry) plus predictive models like AlphaFold, Chai-1, and Boltz-2 embedded directly in the workflow, launched October 2025.
- **Benchling Biologics** — End-to-end antibody R&D solution connecting sequence registration, structure prediction, and developability analytics.

## Achievements

- Grew from a single DNA-editing tool into a seven-app R&D Cloud used by 300,000+ scientists.
- Reached a $6.1B valuation at its 2021 Series F - reportedly a 122x trailing revenue multiple.
- Adopted by 20 of the 50 largest biopharma companies globally.
- Doubled annual recurring revenue for four straight years.
- Launched Benchling AI in 2025, embedding agents and frontier scientific models directly in the lab workflow.

## Latest updates

- **2025-10** — Launched Benchling AI with three agents (Deep Research, Compose, Data Entry) and access to models like AlphaFold, Chai-1, and Boltz-2.
- **2025-10** — Unveiled Benchling Biologics and announced partnerships with NVIDIA and Stanford spinout GXL at Benchtalk 2025.
- **2026-05** — Partnered with Baseten to launch Benchling Inference, on-demand GPU capacity for scientific model training and serving.

## Links

- Website: https://www.benchling.com
- LinkedIn: https://www.linkedin.com/company/benchling
- Twitter/X: https://twitter.com/benchling
- GitHub: https://github.com/benchling
- YouTube: https://www.youtube.com/@Benchling
- Facebook: https://www.facebook.com/benchling

---

Profile page: https://yespress.io/benchling
Published by YesPress — https://yespress.io
Last updated: 2026-06-02